Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:13:31 EST Mon 10 Nov 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

V:HEM - Hemostemix Inc. - https://www.hemostemix.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
HEM - V  4.00.09·0.09518.00.095+0.0055.6329.626610.09  0.095  0.080.425  0.06Nov 07Nov 0415 min RT 2¢
TSX-V - V4.00.09·0.09518.00.09133.910280.085  0.09  0.080.425  0.06Nov 0715 min
NEO ATS - U 0.0922.0240.085  0.09  0.085Nov 0715 min
Alpha - A 0.095+0.0055.66.0020.09  0.095  0.09Nov 0715 min
Omega - O 0.0970.0670.09  0.09  0.08Nov 0715 min
Pure - P 0.096.0050.085  0.09  0.085Nov 0715 min
CX2 - H 0.0991.08110.09  0.09  0.08Nov 0715 min
CXD - D 0.090.41    Sep 1515 min
TriAct - M 0.090.23    15 min

Recent Trades - Last 10 of 61
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:31:16A0.0950.0051,0007 TD Sec1 AnonymousK
15:22:42M0.0950.00520080 National Bank7 TD SecE
14:32:00V0.09 40,00062 Haywood1 AnonymousK
14:23:50V0.09 5007 TD Sec1 Anonymous
14:23:50V0.09 7,00062 Haywood79 CIBCK
14:23:50O0.09 6,00062 Haywood1 AnonymousK
14:23:50H0.09 30,00062 Haywood1 AnonymousK
14:23:50O0.09 30,00062 Haywood1 AnonymousK
14:23:50U0.09 5,00062 Haywood1 AnonymousK
14:23:50O0.09 15,00062 Haywood1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-11-04 23:20C:HEM0.095News ReleaseHemostemix closes $461,230 first tranche of financing
2025-10-30 20:23C:HEM0.095News ReleaseHemostemix talks work in Florida
2025-10-28 15:44C:HEM0.095News ReleaseHemostemix Announces Its Webinar for Florida Vascular Surgeons: Autologous Stem Cell Therapy for CLTI
2025-10-22 18:42C:HEM0.10News ReleaseHemostemix receives Know Your Health trademark in Japan
2025-10-15 20:06C:HEM0.105News ReleaseHemostemix seeks to treat refractory angina
2025-10-09 19:04C:HEM0.11News ReleaseHemostemix applies for vascular dementia study approval
2025-10-08 03:40C:HEM0.11News ReleaseHemostemix receives $330,000 lead order for placement
2025-09-23 18:58C:HEM0.10News ReleaseHemostemix files FDA trial for ACP-01 stem therapy
2025-09-17 07:53C:HEM0.105News ReleaseHemostemix to Present at Life Science Investor Forum
2025-09-16 14:52C:HEM0.10News ReleaseHemostemix to Present Its Clinical Data of the Treatment of Severe Angina
2025-09-11 23:44C:HEM0.12Shares for DebtHemostemix two million shares for debt
2025-09-10 23:04C:HEM0.125News ReleaseHemostemix to issue two million shares for debt
2025-09-09 20:04C:HEM0.115News ReleaseHemostemix arranges $280,594 private placement
2025-09-09 16:46C:HEM0.115News ReleaseHemostemix launches corporate website
2025-09-05 01:43C:HEM0.105News ReleaseHemostemix rolls out VesCell.Health in Florida
2025-09-03 20:03C:HEM0.10News ReleaseHemostemix cheers 17 "years of line gained" by Lindeman
2025-08-29 04:42C:HEM0.11SEDAR Interim MD & ASEDAR Interim MD & A
2025-08-29 04:37C:HEM0.11SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-08-28 19:58C:HEM0.075News ReleaseHemostemix arranges payment plans for VesCell treatment
2025-08-26 20:25C:HEM0.08News ReleaseHemostemix begins face-to-face sales program in Florida